Journal List > Yonsei Med J > v.52(6) > 1030902

Eom, Lee, Yang, Jang, Kim, Lee, Kim, Park, Kong, Shim, Lee, and Kim: Rapid Isolation of Adipose Tissue-Derived Stem Cells by the Storage of Lipoaspirates

Abstract

Purpose

This study examined a rapid isolation method decreasing the time and cost of the clinical application of adipose tissue-derived stem cells (ASCs).

Materials and Methods

Aliquots (10 g) of the lipoaspirates were stored at 4℃ without supplying oxygen or nutrients. At the indicated time points, the yield of mononuclear cells was evaluated and the stem cell population was counted by colony forming unit-fibroblast assays. Cell surface markers, stem cell-related transcription factors, and differentiation potentials of ASCs were analyzed.

Results

When the lipoaspirates were stored at 4℃, the total yield of mononuclear cells decreased, but the stem cell population was enriched. These ASCs expressed CD44, CD73, CD90, CD105, and HLA-ABC but not CD14, CD31, CD34, CD45, CD117, CD133, and HLA-DR. The number of ASCs increased 1×1014 fold for 120 days. ASCs differentiated into osteoblasts, adipocytes, muscle cells, or neuronal cells.

Conclusion

ASCs isolated from lipoaspirates and stored for 24 hours at 4℃ have similar properties to ASCs isolated from fresh lipoaspirates. Our results suggest that ASCs can be isolated with high frequency by optimal storage at 4℃ for 24 hours, and those ASCs are highly proliferative and multipotent, similar to ASCs isolated from fresh lipoaspirates. These ASCs can be useful for clinical application because they are time- and cost-efficient, and these cells maintain their stemness for a long time, like ASCs isolated from fresh lipoaspirates.

INTRODUCTION

Mesenchymal stem cells (MSCs) have two properties; the ability to self-renew1,2 and the ability to differentiate into multiple tissue type lineages, such as cartilage, bone, muscle, ligament, tendon, adipocytes and stromal cells.3-5 MSCs derived from bone marrow were first recognized by Friedenstein and co-workers,6-9 and many studies have since used bone marrow-derived stem cells (BMSCs). Recently, MSCs have been isolated from adipose tissue, umbilical cord blood, peripheral blood, brain, lung, liver, dermis, and skeletal muscle.10-18 MSCs reside in various tissues but can be isolated from bone marrow aspirates, adipose tissues, and the umbilical cord with 100% efficiency.19 Adipose tissue can be obtained with less invasive procedures than other tissues. More importantly, adipose tissue-derived stem cells (ASCs) can be recovered in high quantities because adipose tissues are an abundant reservoir of MSC approximately >100-fold higher than bone marrow.20 Therefore, adipose tissue represents an abundant, practical, and appealing stem cell source for regenerative medicine.
ASCs are isolated using a combination of enzymatic digestion with collagenase and methods that take advantage of their adherence properties.21 It was reported that 2-6×108 mononuclear cells could be obtained from 300 mL of adipose tissue.21 The average frequency of ASCs from lipoaspirates was 0.1-1% of mononuclear cells, and the yield of ASCs was approximately 500-5,000 stem cells per 1 gram of adipose tissue.20,22 Most research groups use the isolation method described by Zuk, et al.21 In brief, adipose tissue or lipoaspirates are treated with collagenase immediately after surgical resection, and the mononuclear cells are plated in cell culture medium at a density of 5×106 mononuclear cells/100-mm culture dish. Subconfluent growth can be observed within two weeks of initial plating. Therefore, to isolate ASCs from 300 mL of lipoaspirates, approximately one hundred 100-mm cell culture dishes are required. This laborious procedure can cause many problems, including cell contamination, increased costs and long isolation times. To improve ASC isolation procedures, we focused on the characteristics of MSCs that were more resistant to unsuitable environments than other somatic cells.23,24 Mylotte, et al.24 reported that MSCs were more resistant to ischemia than cardiomyocytes and that exposure to ischemia did not impair MSC differentiation potential. They further demonstrated that MSCs were resistant to hypoxia (0.5% O2) or inhibitory conditions of mitochondrial respiration with 2,4-dinitrophenol for 72 hours. These results indicate that in the absence of oxygen, MSCs could survive using anaerobic ATP production. Matsumoto, et al.25 reported that aspirated fat could be stored or transported overnight if preserved at 4℃ and that adipose tissue-derived stem cell yield was not reduced by preservation at 4℃ for one day, but they did not describe the effects of local anesthetics on the quantity and quality of viable preadipocytes. Generally, to obtain human lipoaspirates, elective liposuction procedures are performed under lo1000cal anesthesia. Local anesthetics such as articaine/epinephrine and lidocaine strongly impair preadipocyte viability.26 Keck, et al. reported a marked influence of local anesthetics on not only the quantity but also the quality of viable preadipocytes as determined by their ability to differentiate into mature adipocytes.
In our procedures, lipoaspirates were extensively washed with phosphate-buffered saline (PBS) to remove contaminating blood cells and local anesthetics prior to preservation, and in order to exclude the effects of local anesthetics on the viability of preadypocytes and their differentiation into adipocytes. Therefore, in this study, we evaluated the optimal isolation conditions for ASCs from lipoaspirates stored at 4℃ without local anesthetic and a supply of oxygen and nutrients. Our results show that the numbers of mononuclear cells gradually decreased during storage in a time dependent manner, but that, in contrast, ASC isolation was enhanced when lipoaspirates were stored for 24 hours.

MATERIALS AND METHODS

Isolation of adipose tissue-derived stem cells

Human adipose tissue was obtained from three healthy female donors with a mean age of 30.7±7.8 and body mass index of 23.7±3.7 at Park's Cosmetic and Plastic Surgery (Seoul, Korea). The women underwent elective liposuction procedures under anesthesia according to procedures approved by the Institutional Review Board of Ajou University Hospital. Informed consent was obtained from all donors. Mononuclear cells were isolated using a modified protocol described by Zuk, et al.21 In brief, lipoaspirates were extensively washed with PBS to remove contaminating blood cells and local anesthetics. Then, aliquots (10 g) of the washed lipoaspirates were preserved at 4℃ without supplying oxygen or nutrients. At the indicated time points, an aliquot was enzymatically digested at 37℃ for 40 minutes with 0.075% type IA collagenase (Sigma, St. Louis, MO, USA) in PBS. The red blood cell lysis step was omitted to reduce the isolation time because omission of this step caused no difference in yield of mononuclear cells and isolation efficiency of mesenchymal stem cells. The digested lipoaspirates was centrifuged at 1,200 g for 5 minutes, and the pellet was resuspended and passed through a 100-µm mesh filter (Cell Strainer, Becton Dickinson, Franklin Lakes, NJ, USA) to remove debris. Cells were plated in 100-mm culture dishes at a density of 5×106 mononuclear cells with low glucose Dulbecco's minimal essential medium (DMEM) containing 10% fetal bovine serum (FBS) and antibiotics (100 U/mL penicillin G and 100 µg/mL streptomycin). After two days, the medium was changed to remove nonadherent cells. The adhered cells were expanded for seven days, then trypsinized and counted.

Culture and expansion

ASCs were maintained in DMEM supplemented with 10% FBS and 1×penicillin/streptomycin (GibcoBRL, Rockville, MD, USA) in a humidified incubator at 37℃/5% CO2. The medium was changed twice weekly, and cells were passaged with 0.25% trypsin/0.1% EDTA (GibcoBRL) upon reaching 90% confluency. Experiments for proliferation and differentiation were performed at passage 1 to 3. The number of population doublings was calculated using the following formula: log N0/log N1, where N0 is the number of seeding cells and N1 is the number of recovered cells when they were passaged. Doubling time was determined by dividing the total number of hours in culture by the number of doublings.

CFU-F assay

For colony forming unit-fibroblast (CFU-F) assays, cells isolated from lipoaspirates were seeded at 5,000 cells/well in triplicated 6-well plates and fed twice weekly for two weeks. For direct visualization of the colonies, the cells were washed with PBS and fixed in 95% ethanol for five minutes, and then the cells were incubated for 30 minutes at room temperature in 0.5% crystal violet in 95% ethanol. Excess stain was removed by washing with distilled H2O. The plates were dried and the CFU-F units counted. We defined a CFU-F unit as consisting of more than 100 cells using a microscope.

Immunophenotype analysis

ASCs were stained with combinations of saturating amounts of antibodies conjugated with fluorescein isothiocyanate (FITC) or phycoerythrin (PE): CD14-FITC, CD31-PE, CD34-PE, CD44-FITC, CD45-FITC, CD73-PE, CD90-FITC, CD117-PE, CD133-PE, HLA-ABC-FITC, HLA-DR-PE (BD Biosciences, San Jose, CA, USA), and CD105-PE (Ancell, Bayport, MN, USA). A total of 5×105 cells were resuspended in 0.2 mL PBS and incubated with FITC- or PE-conjugated antibodies for 20 minutes at room temperature. FITC- or PE-conjugated mouse IgGs were used as the control isotype at the same concentration as specific primary antibodies. The fluorescence intensity of the cells was evaluated by flow cytometry (FC 500; Beckman Coulter) and the data were analyzed with the CXP software (Beckman Coulter).

Differentiation assays

Adipogenic differentiation

Cells were plated at 2×104 cells/cm2 in 6-well plates and cultured for one week. The medium was then changed to an adipogenic medium [10% FBS, 1 µM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, 10 µg/mL insulin and 100 µM indomethacin in high glucose (HG)-DMEM] for an additional three weeks. In order to determine adipogenic differentiation, the cells were fixed in 4% paraformaldehyde for 10 minutes and stained with fresh Oil red-O solution (Sigma) to show lipid droplets in induced cells.27

Osteogenic differentiation

Cells were plated at 2×104 cells/cm2 in 6-well plates, then induced in the following osteogenic medium for two to three weeks: low glucose (LG)-DMEM medium supplemented with 10% FBS, 10 mM β-glycerophosphate, 10-7 M dexamethasone, and 0.2 mM ascorbic acid (all from Sigma).28 In order to determine osteogenic differentiation, the release of p-nitrophenol from p-nitrophenyl phosphate by the ALP enzyme was observed.29

Neuronal differentiation

Cells were plated at 8×103 cells/cm2 in 6-well plates. After 24 hours, the cells were preinduced for one day with HG-DMEM supplemented with 20% FBS, and then the medium was changed to neurogenic medium (200 µM BHA, 5 mM KCl, 2 mM valproic acid, 10 µM forskolin, 1 µM hydrocortisone, 5 µg/mL insulin in serum-free HG-DMEM).30 Neuron-specific genes were determined by RT-PCR and immunocytochemistry.

Myogenic differentiation

Cells were plated at 1×103 cells/cm2 in 6-well plates. After 24 hours, cells were preinduced for one day with LG-DMEM supplemented with 10% FBS, 3 µM 5-azacytidine, 10 ng/mL fibroblast growth factor-2 (FGF-2), and 0.25 µg/mL amphotericin B. The medium was then changed to a myogenic medium (10% FBS and 10 ng/mL FGF-2 in LG-DMEM)31,32 and muscle cell specific genes were determined by RT-PCR and immunoblotting as previously described.33

Immunoblotting

The cells were washed with ice-cold DPBS and lysed in RIPA buffer [50 mM Tris-HCl, pH 7.5, containing 1% Triton X-100, 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), and 1% sodium deoxycholate] with a protease inhibitor cocktail (Sigma, St. Louis, MO, USA) on ice. The lysate was centrifuged at 13,000 g for 10 min at 4℃. The supernatant was transferred to a new tube, and its protein concentration was measured by using a protein assay kit (Bio-Rad, Hercules, CA, USA). 30 µg proteins were resolved by 10% SDS reducing gel and elcctrophoretically transferred onto polyvinylidene difluoride membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK) using a trans-blot system (Bio-Rad, Hercules, CA, USA). Blots were probed using anti-actin (1 : 1000 dilution; Santa Cruz Biotech, Santa Cruz, CA, USA), anti-myogenin (1 : 1000 dilution; Santa Cruz Biotech, CA, USA), and anti-MyHC (1 : 1000 dilution; Santa Cruz Biotech, CA, USA). The next day, bound primary antibodies were detected with horseradish peroxidase-conjugated secondary antibodies (1 : 2000 dilution; Santa Cruz Biotech, CA, USA), and visualized with an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech, Buckinghamshire, UK).

Immunocytochemistry

The cells were fixed in 10% formalin solution (Sigma), permeabilized with 0.2% Triton X-100 in PBS for 5 min at room temperature, and blocked with 2% FBS in PBS for 30 min at room temperature. They were incubated with a primary antibody specific to NF-L (1 : 100 dilution; Santa Cruz Biotech, CA, USA) for 4℃ overnight, and then labeled with rhodamine-conjugated secondary antibodies (1 : 100, Santa Cruz Biotech) for 1 h at room temperature after primary incubation. The cells were also stained with 1 µg/mL 4', 6-diamino-2-phenylindole (DAPI, Sigma, St. Louis, MO, USA) in order to visualize their nuclei. The slides were observed and photographed under a fluorescent microscope (IX-71, Olympus, Shinjuku-ku, Tokyo, Japan).

RT-PCR

Total RNA was extracted from the cells using the TRIzol Reagent (GibcoBRL, Rockville, MD, USA). A total of 2 µg of RNA was reverse-transcribed with AMV reverse transcriptase XL (TaKaRa, Otsu, Shiga, Japan) for one hour at 42℃ in the presence of oligo-dT primer. PCR was performed using Taq DNA polymerase (BioQuest, Seoul, Korea). Amplified products were electrophoresed on a 2% agarose gel and photographed under an ultraviolet light transilluminator (Bio-Rad, Hercules, CA, USA). The sequences of oligonucleotide primers used for RT-PCR and the expected transcript sizes are listed in Table 1.

Statistical analysis

Data are expressed as mean±standard deviation. Statistical significance was estimated by the Student's t-test and a paired t-test. Significance was defined as p-value of ≤0.05.

RESULTS

Yield of mononuclear cells by processing time

The lipoaspirates were extensively washed with phosphate-buffered saline (PBS) to remove contaminating blood cells and local anesthetics, and then aliquots (10 g) of the washed lipoaspirates were stored at 4℃ until needed. An aliquot of lipoaspirates was digested with type IA collagenase after a total storage period of between 3 and 36 hours, and the recovered mononuclear cells were counted. Interestingly, although the total yield of mononuclear cells from preserved lipoaspirates gradually decreased from 3.06×106 cells/g at three hours post-storage to 0.4×106 cells/g at 36 hours post-storage (Fig. 1A), that of CFU-F and expanded cells during seven days peaked from aliquots preserved for 24 hours (Fig. 1B and C). The ability of mononuclear cells isolated from an aliquot preserved for 24 hours (yield of 2.8±0.08%) to form a CFU-F unit was -4.7 times higher than those stored for only three hours (yield of 0.6±0.2%). Also, the expanded cell number after seven days was 3.9 times higher in the aliquots that were preserved for 24 hours.

Cell surface markers

In order to characterize the surface phenotype of ASCs isolated from an aliquot preserved for 24 hours, cell surface markers were examined at the third passage. Flow cytometric results showed that ASCs isolated after preservation for 24 hours were positive for CD44, CD90, CD73, CD105, and HLA-ABC. In addition, expression of CD14, CD31, CD34, CD45, CD117, CD133, and HLA-DR was not observed (Fig. 2). This phenotype is similar to the phenotype of stem cells isolated from the bone marrow, umbilical-cord blood, and umbilical cord tissue.34 It is also consistent with the ASC phenotype reported by Gronthos and Zuk.35,36

Proliferation capacity

In order to examine the in vitro proliferative potential of ASCs isolated from an aliquot preserved for 24 hours at 4℃, we replated the cells at 1,000 cells/cm2 every 8-10 days until their initial population doubling (PD) time increased by more than three times. The proliferative potential was retained even at passage 12 (Fig. 3), and cell numbers increased 1×1014 fold. The population doubling time at early passages was maintained from about 39 to 50 hours until passage 6, and then gradually increased until passage 12. The PD times of passages 12 and 13 were 104 and 175 hours, respectively.

Differentiation capacity

Previous studies have demonstrated the osteogenic, chondrogenic, adipogenic, myogenic, cardiomyogenic, and neurogenic potential of ASCs. In order to examine the differentiation potentials of ASCs isolated from an aliquot preserved for 24 hours at 4℃, osteogenic, adipogenic, myogenic, or neurogenic differentiation of ASCs was induced. In Fig. 4, alkaline phosphatase activity, a marker of osteogenesis, was detected at high levels (Fig. 4A), and Oil-Red-O stain accumulated in intracellular lipid-filled droplets of adipocytes differentiated from ASCs (Fig. 4B). In myogenic or neurogenic differentiation of ASCs, markers of skeletal muscle cells (MyoD, Myogenin, dystrophin, MCK, and MyHC) or neuronal cells (neuroD, NF-L, nestin) were expressed in mRNA (Fig. 4C and E) and protein levels (Fig. 4D and F).

DISCUSSION

We report an optimal ASC isolation method that reduces cell contamination or cost and time required by preserving lipoaspirates at 4℃ for 24 hours. We carefully evaluated the phenotype, proliferation and differentiation potentials of ASCs isolated from lipoaspirates preserved at 4℃ for 24 hours, and our results are in agreement with previous reports34-37 that state that the phenotype of ASCs isolated from lipoaspirates preserved at 4℃ for 24 hours was similar to that of ASCs isolated immediately after surgery or BMSC. In fact, although we directly compared the characteristics of stem cells isolated at 3- and 24-hour time points from eight donors, we found no differences (data not shown). Our procedure reduced the required time for isolating stem cells from about 14 to 7 days and increased the total yield of stem cells from adipose tissue. We suggest that of the reduced time required for isolation and the increased yield of stem cells might be the results of enrichment by increased storage time and the resistance of stem cells to environments unsuitable for somatic cells. In fact, Mylotte, et al.24 reported that MSCs were more resistant to unsuitable environments, such as ischemia, hypoxia (0.5% O2), and the inhibitory conditions of mitochondrial respiration. These results highlighted the fact that mesenchymal stem cells from lipoaspirates could be enriched by an unsuitable environment such as cold preservation without oxygen or nutrients.
In order to gain the optimal therapeutic effects of stem cell for clinical application, some issues must be considered carefully. First, stemness, as evaluated by proliferation and differentiation potentials, must be maintained during ex vivo expansion of stem cells. It is well established that the stemness of stem cells is gradually lost after prolonged cell culture and, thus, that maintenance of stemness may play a pivotal role in the regeneration of damaged cells or tissues. In our results, PD time of ASCs isolated from lipoaspirates preserved at 4℃ for 24 hours was below 75 hours up to passage 11. Further, expression of stemness-related transcription factors, Klf4, Nanog, Sox2, and Oct4 was not decreased (data not shown). Taken together, ASCs isolated by our protocols were able to expand sufficiently for a relatively long time in culture without loss of stemness. Second, abundant quantities of stem cells are required for clinical trials. To obtain sufficient stem cells within a short period of time, it is important that stem cell sources have high reservoirs of stem cells. In addition, these stem cells must be isolated as rapidly as possible. Therefore, if MSCs were isolated rapidly from adipose tissue using our procedure in numbers approximately 100+ fold than from bone marrow,20 ASCs may provide the best stem cells for clinical trials.
In summary, we found that the required time for the isolation of stem cells decreased and the yield of stem cells increased after preservation of lipoaspirates at 4℃ for 24 hours. The characteristics of ASCs isolated by our protocol were similar to MSCs of bone marrow, adipose tissue, and umbilical cord blood; this was in accordance with previous reports.34-37 In conclusion, we have demonstrated that stem cells derived from adipose tissue could be isolated more rapidly by preservation at 4℃, and that these stem cells had similar stemness and characteristics to other stem cells. These results provide important information regarding the optimal isolation of mesenchymal stem cells from adipose tissue for enhancing clinical utility.

Figures and Tables

Fig. 1
Isolation of ASCs from lipoaspirates preserved at 4℃. (A) Yields of mononuclear cells isolated from lipoaspirates. Mononuclear cells were isolated from lipoaspirates preserved at 4℃ for the indicated times as described in the Materials and Methods section, and then viable mononuclear cells were counted by staining with trypan blue. (B) Recovery of cells at day 7. Each set of mononuclear cells was isolated at the indicated times and cultured in 100-mm culture dishes at a density of 5×106 cells. On day 7, the expanded cells were counted. (C) Clonogenic ability of mononuclear cells isolated from lipoaspirates. Five thousand mononuclear cells were plated in 6-well plates. They were cultured for two weeks, and then colony forming unit-fibroblasts (CFU-F) were stained with crystal violet. A colony consisting of more than 100 cells was counted microscopically. Representative histograms of three independent experiments are shown, and error bars represent the standard deviation. ASCs, adipose tissue-derived stem cells.
ymj-52-999-g001
Fig. 2
Expression of cell surface markers of ASCs isolated from lipoaspirates preserved for 24 hours. Expression of cell surface markers of ASCs isolated from lipoaspirates preserved for 24 hours was determined by flow cytometry as described in the Materials and Methods section. CD14-FITC and CD105-PE, CD44-FITC and CD133-FITC, CD45-FITC and CD34-PE, and HLA-ABC-FITC and HLA-DR-PE were double stained. ASCs, adipose tissue-derived stem cells; FITC, fluorescein isothiocyanate; PE, phycoerythrin.
ymj-52-999-g002
Fig. 3
Proliferation potentials of ASCs isolated from lipoaspirates preserved for 24 hours. ASCs were cultured in 6-well plates at a density of 1000 cells/cm2. When the cells grew confluent, the total cell numbers were counted and then re-cultured at the same density. These procedures were repeated until cell growth stopped. Numbers of cells (-▪-) and population doubling times (histogram) were represented at each passage. Representative histograms of three independent experiments are shown, and error bars represent the standard deviation. ASCs, adipose tissue-derived stem cells.
ymj-52-999-g003
Fig. 4
Differentiation potentials of ASCs isolated from lipoaspirates preserved for 24 hours. Passage 1 cells were seeded and differentiated into adipocytes, osteoblasts, muscle cells, or neuronal cells as described in the Materials and Methods section. Osteogenic (A) or adipogenic differentiation (B) were evaluated by assaying the alkaline phosphatase activity or Oil-Red O staining, respectively. To evaluate differentiation potentials of ASCs into muscle (C and D) or neuronal cells (E and F), we investigated the expression of several markers (myogenic; MyoD, Myogenin, Dystrophin, MCK and neurogenic; NeuroD, NF-L, Nestin) by RT-PCR, immunoblotting (myogenic; Myogenin and MyHC), and immucocytochemistry (neurogenic; NF-L). ASCs, adipose tissue-derived stem cells; MyoD, class I myosin; MCK, muscle creatine kinase; NeuroD, neurogenic differentiation; NF-L, neurofilament light polypeptide; DAPI, 4', 6-diamino-2-phenylindole; MyHC, myosin heavy chain.
ymj-52-999-g004
Table 1
RT-PCR Primers for Validation of Gene Expression
ymj-52-999-i001

GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MyoD, class I myosin; MCK, muscle creatine kinase; NeuroD, neurogenic differentiation; NF-L, neurofilament light polypeptide.

ACKNOWLEDGEMENTS

We are grateful to Kijong Rhee for his critical review of the manuscript. This work was supported by a grant from Lifeliver. Co., Ltd.

Notes

The authors have no financial conflicts of interest.

References

1. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000. 97:3213–3218.
crossref
2. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002. 20:530–541.
crossref
3. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992. 13:81–88.
crossref
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999. 284:143–147.
crossref
5. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997. 276:71–74.
crossref
6. Friedenstein AJ. Precursor cells of mechanocytes. Int Rev Cytol. 1976. 47:327–359.
crossref
7. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 1987. 20:263–272.
crossref
8. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968. 6:230–247.
9. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988. 136:42–60.
crossref
10. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001. 98:2396–2402.
crossref
11. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003. 174:101–109.
crossref
12. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000. 109:235–242.
crossref
13. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002. 30:896–904.
crossref
14. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol. 2001. 153:1133–1140.
crossref
15. Lee MW, Yang MS, Park JS, Kim HC, Kim YJ, Choi J. Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood. Int J Hematol. 2005. 81:126–130.
crossref
16. Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002. 30:870–878.
crossref
17. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec. 2001. 264:51–62.
crossref
18. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000. 2:477–488.
crossref
19. Rebelatto CK, Aguiar AM, Moretão MP, Senegaglia AC, Hansen P, Barchiki F, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood). 2008. 233:901–913.
crossref
20. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005. 52:2521–2529.
crossref
21. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001. 7:211–228.
crossref
22. Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005. 54:132–141.
crossref
23. Hoffmann J, Glassford AJ, Doyle TC, Robbins RC, Schrepfer S, Pelletier MP. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. Thorac Cardiovasc Surg. 2010. 58:136–142.
crossref
24. Mylotte LA, Duffy AM, Murphy M, O'Brien T, Samali A, Barry F, et al. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells. 2008. 26:1325–1336.
crossref
25. Matsumoto D, Shigeura T, Sato K, Inoue K, Suga H, Kato H, et al. Influences of preservation at various temperatures on liposuction aspirates. Plast Reconstr Surg. 2007. 120:1510–1517.
crossref
26. Keck M, Zeyda M, Gollinger K, Burjak S, Kamolz LP, Frey M, et al. Local anesthetics have a major impact on viability of preadipocytes and their differentiation into adipocytes. Plast Reconstr Surg. 2010. 126:1500–1505.
crossref
27. Preece A. A manual for histologic technicians. 1972. Boston: Little, Brown.
28. Hu Y, Liao L, Wang Q, Ma L, Ma G, Jiang X, et al. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med. 2003. 141:342–349.
crossref
29. Martin JY, Dean DD, Cochran DL, Simpson J, Boyan BD, Schwartz Z. Proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63) cultured on previously used titanium surfaces. Clin Oral Implants Res. 1996. 7:27–37.
crossref
30. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000. 61:364–370.
crossref
31. Santa María L, Rojas CV, Minguell JJ. Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp Cell Res. 2004. 300:418–426.
crossref
32. Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood). 2004. 229:623–631.
crossref
33. Eom YW, Lee JE, Yang MS, Jang IK, Kim HE, Lee DH, et al. Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts. Biochem Biophys Res Commun. 2011. 408:167–173.
crossref
34. Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009. 259:150–156.
crossref
35. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol. 2001. 189:54–63.
crossref
36. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002. 13:4279–4295.
crossref
37. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005. 129:118–129.
crossref
TOOLS
Similar articles